BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio % : 0.00% (As of Feb. 2024)

View and export this data going back to 2017. Start your Free Trial

What is BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio %?

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio for the quarter that ended in Feb. 2024 was 0.00%.

As of Feb. 2024, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio % Historical Data

The historical data trend for BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio % Chart

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Sloan Ratio %

Get a 7-Day Free Trial

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Semi-Annual Data
	Feb19	Aug19	Feb20	Aug20	Feb21	Aug21	Feb22	Aug22	Feb23	Aug23	Feb24
Sloan Ratio %	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio %

For the Asset Management subindustry, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio % falls into.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Sloan Ratio	=	(Net Income (A: Aug. 2023 )	-	Cash Flow from Operations (A: Aug. 2023 )
	-	Cash Flow from Investing (A: Aug. 2023 ))	/	Total Assets (A: Aug. 2023 )
	=	(13.713	-	14.264
	-	0)	/	176.51
	=	-0.31%

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio for the quarter that ended in Feb. 2024 is calculated as

Sloan Ratio	=	(Net Income (TTM)	-	Cash Flow from Operations (TTM))
	-	Cash Flow from Investing (TTM))	/	Total Assets (Q: Feb. 2024 )
	=	(21.118	-	1.168
	-	0)	/	188.676
	=	10.57%

For company reported semi-annually, GuruFocus uses latest two semi-annual data as the TTM data. BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Net Income for the trailing twelve months (TTM) ended in Feb. 2024 was 8.824 (Aug. 2023 ) + 12.294 (Feb. 2024 ) = $21.12 Mil.
BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash Flow from Operations for the trailing twelve months (TTM) ended in Feb. 2024 was 1.45 (Aug. 2023 ) + -0.282 (Feb. 2024 ) = $1.17 Mil.
BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Cash Flow from Investing for the trailing twelve months (TTM) ended in Feb. 2024 was 0 (Aug. 2023 ) + 0 (Feb. 2024 ) = $0.00 Mil.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund (NYSE:DCF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Sloan Ratio % Related Terms

Thank you for viewing the detailed overview of BNY Mellon Alcentra Global Creditome 2024 Target Term Fund's Sloan Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

BNY Mellon Alcentra Global Creditome 2024 Target Term Fund Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc (NYSE:DCF) » Definitions » Sloan Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o BNY Mellon Investment Adviser, Inc., 240 Greenwich Street, New York, NY, USA, 10286

Website

https://www.bnymellonim.com

BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund Inc is a diversified closed-end management investment company. Its investment objectives are to seek high current income and to return at least the Fund's original NAV to holders of record of common shares on or about the termination date.

Executives

Bushra Mannan	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Irene Papadoulis	other: Director of BNYMIA (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Ping Jiang	other: Dir. of Invest. Oversight (1)	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Bradley J Skapyak	officer: President	200 PARK AVENUE, NEW YORK NY 10166
Joseph Martella	officer: VP	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10288
Daniel Goldstein	officer: VP	240 GREENWICH STREET, NEW YORK NY 10286
Robert J. Pomeroy	officer: VP; Investment Adviser	C/O BNY MELLON INVESTMENT ADVISER, INC., 240 GREENWICH STREET, NEW YORK NY 10286
Vinay Patel	other: Head of Finance of Sub-Adviser	200 PARK AVE, NEW YORK CITY NY 10166
Alcentra Ny, Llc	other: Sub-Adviser	200 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10166
Brandon Chao	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Laurence Raven	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Ross Curran	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Cathy Bevan	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Daire Wheeler	other: Portfolio Mgr of Sub-Adviser	200 PARK AVENUE, NEW YORK CITY NY 10166
Eric Larsson	other: Portfolio Mgr of Sub-Adviser	C/O ALCENTRA NY LLC, 200 PARK AVENUE, NEW YORK CITY NY 10166